Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Elite Pharmaceuticals Inc (ELTP) Message Board

If you add 10% to the common, in theory the value

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 2146
Posted On: 11/28/2012 6:25:45 PM
Posted By: tangerine
Re: Couch #295

If you add 10% to the common, in theory the value of the stock would be worth 10% less. Now buying 50m shares at .10 means that the company believes their investment of 50m at .10 is worth a lot more then .10. How else would you be able to sell 50m shares on the market unless it were.



Its why the stock went to .12. The only thing holding this company back ultimately is cash. Thats a real investment/company point of view. Bashers yell about dilution because they try to trigger a visceral effect.



If Socius is willing to take up to 50m shares at .10, ask yourself what the value of the stock really is....



Personally I think Socius is only done if necessary because the Novel deal will take a while or to provide leverage on the same or another deal.



I have no issues with the Socius deal because it takes away the real overhang on the company which is cash available for operations and R&D.



The stock should be in the 20s or a lot higher right now just based on the impending launches, revenue growth, Novel and ART.



Right now we are trading at about a PE of 10 which is low and that is without considering future growth, Novel, impending launches and Phendimetrazine,



(0)
(0)




Elite Pharmaceuticals Inc (ELTP) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us